Genesco (NYSE: GCO) CEO awarded 74,832 restricted shares under equity plan

Rhea-AI Filing Summary

VAUGHN MIMI ECKEL reported acquisition or exercise transactions in this Form 4 filing.

GENESCO INC reported that Board Chair, President & CEO Mimi Eckel Vaughn received a grant of 74,832 shares of Common Stock on April 2, 2026. The award is restricted stock granted under the Third Amended and Restated 2020 Equity Incentive Plan and carries no purchase price. Following this equity grant, Vaughn directly holds 450,328 shares of Genesco common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider VAUGHN MIMI ECKEL

Role Board Chair, President & CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	74,832	$0.00	--

Holdings After Transaction: Common Stock — 450,328 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 74,832 shares Post-transaction holdings: 450,328 shares Grant price per share: $0.0000 per share

3 metrics

Restricted stock grant 74,832 shares Common Stock awarded on April 2, 2026

Post-transaction holdings 450,328 shares Total common shares directly held after grant

Grant price per share $0.0000 per share Indicates compensation grant, not open-market purchase

Key Terms

restricted stock, Equity Incentive Plan, Form 4, transaction code A

4 terms

restricted stock financial

"Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Equity Incentive Plan financial

"under the Third Amended and Restated 2020 Equity Incentive Plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code A financial

"transaction_code_description": "Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VAUGHN MIMI ECKEL

(Last) (First) (Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE TENNESSEE 37214

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Board Chair, President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		74,832(1)	A	$0.00	450,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan.

	Scott E. Becker, Attorney-in-Fact	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Genesco (GCO) report for Mimi Eckel Vaughn?

Genesco reported that Board Chair, President & CEO Mimi Eckel Vaughn received a grant of 74,832 shares of common stock. The award was recorded as a Form 4 transaction with code A, indicating a grant or award rather than an open-market share purchase.

Was the Genesco (GCO) CEO’s 74,832-share award an open-market stock purchase?

No, the 74,832 shares reported for Genesco’s CEO were a restricted stock grant, not an open-market purchase. The filing shows a price per share of $0.0000, indicating compensation under an equity incentive plan instead of a transaction where the insider paid cash.

How many Genesco (GCO) shares does CEO Mimi Eckel Vaughn hold after this grant?

After receiving the restricted stock grant, Mimi Eckel Vaughn directly holds 450,328 shares of Genesco common stock. This figure, disclosed in the Form 4, reflects her total direct ownership immediately following the 74,832-share equity award transaction on April 2, 2026.

What plan governed the 74,832-share restricted stock grant at Genesco (GCO)?

The 74,832-share restricted stock grant to Mimi Eckel Vaughn was made under Genesco’s Third Amended and Restated 2020 Equity Incentive Plan. The footnote specifies that the shares are restricted stock issued pursuant to this plan, highlighting their role as part of the company’s long-term compensation program.

How is the CEO’s 74,832-share Genesco (GCO) grant classified in the Form 4?

The grant is classified with transaction code A, which indicates a grant, award, or other acquisition. The normalized data describe it as a grant or award acquisition of non-derivative common stock, confirming it is compensation-related rather than a discretionary market trade or sale.